SCHEMBL2178358

SCHEMBL2178358

COc1ccc2cc(-c3ccnc(NCCc4ccccc4OC)n3)cc(N(C(=O)O)C(C)(C)C)c2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CASR P41180 1/20 0.42
MTNR1A P48039 9/20 0.40
MTNR1B P49286 6/20 0.40
GSK3B P49841 1/20 0.38
LMNA P02545 2/20 0.38
PTPN7 P35236 1/20 0.38
DUSP3 P51452 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
NQO2 P16083 1/20 0.37
MKNK1 Q9BUB5 2/20 0.37
MKNK2 Q9HBH9 1/20 0.37
MAPK8 P45983 1/20 0.37
PIK3CG P48736 1/20 0.37
CAMKK2 Q96RR4 1/20 0.37
USP2 O75604 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
CYP2C19 P33261 1/20 0.36
CLK4 Q9HAZ1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2179518 0.93 CASR (0.39) CASRMTNR1AMTNR1BNQO2MKNK1
SCHEMBL2179735 0.88 ACP1 (0.44) MTNR1AMTNR1BMKNK1MKNK2CYP1A2
SCHEMBL2178583 0.88 CCNT1 (0.45) CASRMKNK1MKNK2CLK4
SCHEMBL2177853 0.88 CCNT1 (0.46) LMNACYP1A2CYP3A4CYP2C19CLK4
SCHEMBL2178911 0.87 CASR (0.39) CASRMTNR1AMTNR1BMKNK1PIK3CG
SCHEMBL2176860 0.86 HDAC3 (0.38) GSK3BLMNAMKNK1MKNK2PIK3CG
SCHEMBL2178733 0.86 MKNK1 (0.48) NQO2MKNK1CYP2D6CLK4
SCHEMBL2180425 0.85 HDAC3 (0.44) GSK3BMKNK1MKNK2CYP1A2CYP3A4
SCHEMBL2177434 0.84 VNN1 (0.42) MKNK1CYP1A2CYP3A4CYP2D6CLK4
SCHEMBL2179774 0.84 CLK4 (0.50) MKNK1CLK4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds ARQULE, INC. (US) 2011-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110166137-A1 Substituted Naphthalenyl-Pyrimidine Compounds DPYD, TP53, TYMP CASR 4176/4885MTNR1A 1222/4885MTNR1B 1015/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.